Treatment of Recalcitrant Acrodermatitis Continua of Hallopeau with Brodalumab

Milani-Nejad, N.; Kaffenberger, J.

Journal of Drugs in Dermatology Jdd 18(10): 1047

2019


ISSN/ISBN: 1545-9616
PMID: 31603633
Document Number: 17970
To the Editor: Acrodermatitis continua of Hallopeau (ACH) is a relatively rare chronic disorder with clinical findings of pustules and erythematous plaques on the digits.1 Although it is a variant of pustular psoriasis, it can be resistant to multiple lines of therapy. We describe for the first time a patient with recalcitrant ACH successfully treated with brodalumab, an interleukin-17 receptor A (IL-17RA) blocking antibody.

Document emailed within 1 workday
Secure & encrypted payments

Treatment of Recalcitrant Acrodermatitis Continua of Hallopeau with Brodalumab